ICON Public
ICLR | NASDAQ
$191.40
-$3.25 (-1.67%)
At close: Nov 16, 2026, 4:00 PM ET
$191.40
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
ICON Public Company Profile
Company profile explainedCompany Profile
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Key Executives
| Name | Position |
|---|---|
| Barry Balfe | Chief Executive Officer & Director |
| Nigel Clerkin | Chief Financial Officer |
| Thomas N. O'Leary | Chief Information Officer |
| David Green | Vice President of Marketing |
| Diarmaid Cunningham | Chief Administrative Officer, General Counsel & Company Secretary |
| Joe Cronin | Chief Human Resources Officer |
| John Climax | Founder & Independent Non-Executive Director |
| Lyons Emer | Chief Accounting Officer |
| Niamh Murphy | Director of Corporate Communications |
| Steve Empoliti | Chief Commercial Officer |
ICON Public
| Country | Ireland |
| IPO Date | May 15, 1998 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 40,200 |
| CEO | Barry Balfe |
Contact Details
South County Business Park Dublin,
DU D18 X5R3 Ireland
Stock Details
| Ticker Symbol | ICLR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001060955 |
| CUSIP Number | G4705A100 |
| ISIN Number | IE0005711209 |
| SIC Code | 8731 |
Recent News
- 4 days ago / fool.comICON: 3 Key Takeaways for Long-Term Investors
- 6 days ago / businesswire.comICON to Participate at Upcoming Investor Conferences
- 12 days ago / prnewswire.comROYAL CARIBBEAN ANNOUNCES SUMMER 2028 CARIBBEAN LINEUP ACROSS FOUR ICON CLASS SHIPS AND NEWLY AMPLIFIED VACATIONS
- 19 days ago / seekingalpha.comICON Public Limited Company (ICLR) Q3 2026 Earnings Call Transcript
- 20 days ago / marketbeat.comWhat Icon (ICLR) Said on Its Q3 Earnings Call
- 20 days ago / zacks.comIcon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
- 28 days ago / prnewswire.comBuild-A-Bear Workshop Unveils Three Specialty Shop Experiences Coming to New ICON Park Orlando Destination on Nov. 5
- 28 days ago / zacks.comAnalysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
- 1 month ago / prnewswire.comBuild-A-Bear Unveils New ICON Park Experiences Ahead of Grand Opening
- 3 months ago / zacks.comIcon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Add to Watchlist
Select watchlists to add or remove ICLR